Yield10 Bioscience (YTEN)

Overall impact
B (62)

Commentary

Yield10 Bioscience is a strong overall performer. With a 'B' rating of 61.8 for overall impact (67th percentile compared to all companies), Yield10 Bioscience ranks 28th out of 151 industry peers, behind Northern Technologies International, Gulf Resources, Flexible Solutions International and 24 others, and ahead of Amyris, Aemetis, Ingevity and 120 others. On top material causes for Yield10 Bioscience's industry (Chemicals), Yield10 Bioscience performs well in Humane Treatment of Animals (96.2 score), Reduced Waste (95.3) and Child and Maternal Health (95.0) and performs poorly in Reduced Green House Gas Emissions (12.3 score).
Impact
Cause YTEN
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company

Yield10 Bioscience

Employees
29
Sector
Materials
Industry
Chemicals
Sub-industry
Specialty Chemicals
SASB industry
Chemicals
Headquarters
Ma, United States
Share classes
YTEN
Description
Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for the production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts. On December 6, 2024, Yield10 Bioscience, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Material causes
Ethos considers the following causes material for Yield10 Bioscience, based on its industry sub-industry Specialty Chemicals. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.